Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic

about

Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic

Item

http://www.wikidata.org/entity/Q58601336

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 18 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@en

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@nl

type

Item

label

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@en

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@nl

prefLabel

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@en

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@nl

P1476

Preservation of myocardial con ...... oxygen delivery biotherapeutic

@en

P2093

Alexandra Loucks

http://www.w3.org/2001/XMLSchema#string

Amy L Lesneski

http://www.w3.org/2001/XMLSchema#string

Ana Krtolica

http://www.w3.org/2001/XMLSchema#string

Andrew Davis

http://www.w3.org/2001/XMLSchema#string

Brian D. Goudy

http://www.w3.org/2001/XMLSchema#string

Janel Long-Boyle

http://www.w3.org/2001/XMLSchema#string

Jason Boehme

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Fineman

http://www.w3.org/2001/XMLSchema#string

Jogarao V S Gobburu

http://www.w3.org/2001/XMLSchema#string

Jonathan A Winger

http://www.w3.org/2001/XMLSchema#string

P2860

Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes

A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers

Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements

Bench-to-bedside review: the effects of hyperoxia during critical illness

The vulnerable microcirculation in the critically ill pediatric patient

Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis

The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery

Endothelium-derived mediators and hypoxic pulmonary vasoconstriction.

Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Mortality rates in pediatric septic shock with and without multiple organ system failure.

P304

e2005924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PBIO.2005924

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emin Maltepe

P577

2018-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30335746

http://www.w3.org/2001/XMLSchema#string

P921

hypoxia

P932

6193608

http://www.w3.org/2001/XMLSchema#string